Pathologic alterations of the heart and the kidney in patients with ankylosing spondylitis

U Lange1, G Stapfer, T Ditting

  • 1Kerckhoff Clinic and Foundation - Department of Rheumatology, University of Giessen, Bad Nauheim, Germany. u.lange@kerckhoff-klinik.de

Insights

Cardiac abnormalities are common in ankylosing spondylitis (AS) patients, but kidney disease is rare and likely unrelated to AS. This study investigated cardiac and renal issues in AS patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Nephrology

Background:

  • Ankylosing spondylitis (AS) is associated with various heart and kidney lesions, but their frequency and specificity remain debated.
  • Previous studies have controversially discussed the prevalence of these cardiac and renal alterations in AS patients.

Purpose of the Study:

  • To determine the frequency of cardiac and renal alterations in ankylosing spondylitis (AS) outpatients.
  • To assess the clinical and demographic factors associated with these potential comorbidities in AS.

Main Methods:

  • Studied outpatients diagnosed with ankylosing spondylitis (AS).
  • Evaluated cardiac and renal function through echocardiography, electrocardiography, and glomerular filtration rate (GFR) measurements.
  • Collected clinical and demographic data, including comorbidities like hypertension and diabetes mellitus.

Main Results:

  • 77 AS patients (84.4% male, mean age 48.3 years) were included. Hypertension (36.4%) and diabetes (13.0%) were noted.
  • Cardiac abnormalities were found in 37.3% of patients, including valvular insufficiency and conduction blocks. Older age and longer disease duration correlated with cardiac issues.
  • Impaired renal function suggestive of chronic kidney disease was rare, present in only 3.9% of patients.

Conclusions:

  • Cardiac abnormalities are frequent in ankylosing spondylitis (AS) patients, particularly in older individuals with longer disease duration.
  • Renal disease appears uncommon in AS patients and is often attributable to non-AS related conditions.
  • Chronic kidney disease may not be a significant extraskeletal manifestation of AS, or AS has a limited impact on renal integrity.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...